Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1991 1
1992 2
1999 1
2003 2
2004 1
2005 2
2008 1
2009 1
2011 1
2014 1
2016 1
2021 1
2022 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Forty-Eight Week Outcomes of a Site-Randomized Trial of Combined Cognitive Behavioral Therapy and Medication Management Algorithm for Treatment of Depression Among Youth With HIV in the United States.
Brown LK, Baltrusaitis K, Kennard BD, Emslie GJ, Chernoff M, Buisson S, Lypen K, Whiteley LB, Traite S, Krotje C, Knowles K, Townley E, Deville J, Wilkins M, Reirden D, Paul M, Beneri C, Shapiro DE; IMPAACT 2002 Team. Brown LK, et al. Among authors: buisson s. J Acquir Immune Defic Syndr. 2022 Nov 1;91(3):296-304. doi: 10.1097/QAI.0000000000003058. Epub 2022 Jul 20. J Acquir Immune Defic Syndr. 2022. PMID: 35839439 Free PMC article. Clinical Trial.
Gene expression profiling in male genital lichen sclerosus.
Edmonds E, Barton G, Buisson S, Francis N, Gotch F, Game L, Haddad M, Dinneen M, Bunker C. Edmonds E, et al. Among authors: buisson s. Int J Exp Pathol. 2011 Oct;92(5):320-5. doi: 10.1111/j.1365-2613.2011.00779.x. Epub 2011 Jun 30. Int J Exp Pathol. 2011. PMID: 21718371 Free PMC article.
Site-Randomized Controlled Trial of a Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression Among Youth Living With HIV in the United States.
Brown LK, Chernoff M, Kennard BD, Emslie GJ, Lypen K, Buisson S, Weinberg A, Whiteley LB, Traite S, Krotje C, Harriff L, Townley E, Bunch A, Purswani M, Shaw R, Spector SA, Agwu A, Shapiro DE; IMPAACT 2002 team. Brown LK, et al. Among authors: buisson s. J Acquir Immune Defic Syndr. 2021 Dec 15;88(5):497-505. doi: 10.1097/QAI.0000000000002790. J Acquir Immune Defic Syndr. 2021. PMID: 34483297 Free PMC article. Clinical Trial.
Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors.
Yang H, Buisson S, Bossi G, Wallace Z, Hancock G, So C, Ashfield R, Vuidepot A, Mahon T, Molloy P, Oates J, Paston SJ, Aleksic M, Hassan NJ, Jakobsen BK, Dorrell L. Yang H, et al. Among authors: buisson s. Mol Ther. 2016 Nov;24(11):1913-1925. doi: 10.1038/mt.2016.114. Epub 2016 Jun 6. Mol Ther. 2016. PMID: 27401039 Free PMC article.
Targeting of the dual oxidase 2 N-terminal region to the plasma membrane.
Morand S, Agnandji D, Noel-Hudson MS, Nicolas V, Buisson S, Macon-Lemaitre L, Gnidehou S, Kaniewski J, Ohayon R, Virion A, Dupuy C. Morand S, et al. Among authors: buisson s. J Biol Chem. 2004 Jul 16;279(29):30244-51. doi: 10.1074/jbc.M405406200. Epub 2004 May 18. J Biol Chem. 2004. PMID: 15150274 Free article.
Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study.
Lowenthal ED, Chapman J, Ohrenschall R, Calabrese K, Baltrusaitis K, Heckman B, Yin DE, Agwu AL, Harrington C, Van Solingen-Ristea RM, McCoig CC, Adeyeye A, Kneebone J, Chounta V, Smith-Anderson C, Camacho-Gonzalez A, D'Angelo J, Bearden A, Crauwels H, Huang J, Buisson S, Milligan R, Ward S, Bolton-Moore C, Gaur AH; IMPAACT 2017 Collaborators; IMPAACT 2017 Team. Lowenthal ED, et al. Among authors: buisson s. Lancet HIV. 2024 Apr;11(4):e222-e232. doi: 10.1016/S2352-3018(23)00301-6. Lancet HIV. 2024. PMID: 38538161 Clinical Trial.
21 results